Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 5,944,000 | 5,475,000 | 5,040,000 | 5,452,000 | 5,019,000 |
| Cost of Goods | 1,167,000 | 916,000 | 942,000 | 1,119,000 | 1,094,000 |
| Gross Profit | 4,777,000 | 4,559,000 | 4,098,000 | 4,333,000 | 3,925,000 |
| Operating Expenses | 2,892,000 | 2,707,000 | 2,411,000 | 4,748,000 | 2,965,000 |
| Operating Income | 1,885,000 | 1,852,000 | 1,687,000 | -415,000 | 960,000 |
| Interest Expense | 197,000 | 164,000 | 126,000 | 129,000 | 128,000 |
| Other Income | -41,000 | -10,000 | -165,000 | -493,000 | -145,000 |
| Pre-tax Income | 1,647,000 | 1,678,000 | 1,396,000 | -1,037,000 | 687,000 |
| Income Tax | 408,000 | 312,000 | 374,000 | -227,000 | 181,000 |
| Net Income Continuous | 1,239,000 | 1,366,000 | 1,022,000 | -810,000 | 506,000 |
| Net Income | $1,239,000 | $1,366,000 | $1,022,000 | $-810,000 | $506,000 |
| EPS Basic Total Ops | 0.75 | 0.84 | 0.64 | -0.51 | 0.32 |
| EPS Basic Continuous Ops | 0.75 | 0.84 | 0.64 | -0.51 | 0.32 |
| EPS Diluted Total Ops | 0.74 | 0.83 | 0.63 | -0.50 | 0.31 |
| EPS Diluted Continuous Ops | 0.74 | 0.84 | 0.64 | -0.50 | 0.31 |
| EBITDA(a) | $2,112,000 | $2,042,000 | $1,845,000 | $-222,000 | $1,152,000 |